本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

282.01
-2.6900-0.94%
成交量:1.96萬
成交額:560.30萬
市值:56.22億
市盈率:29.04
高:285.64
開:285.63
低:282.01
收:284.70
52周最高:326.63
52周最低:163.45
股本:1,993.56萬
流通股本:1,935.39萬
量比:1.76
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
淨資產收益率:21.96%
總資產收益率:3.99%
市淨率:5.81
市盈率(LYR):46.00

資料載入中...

2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]